Clinical Trial Update: Adjunctive Supplementation of Antioxidants (Vitamins E + C) Plus Omega-3 Fatty Acids [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating adjunctive supplementation with vitamins E and C plus omega-3 fatty acids for schizophrenia was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Omega-3 fatty acids (omega-3 fatty acids)
• Vitamin C (ascorbic acid)
• Vitamin E (tocopherol)

Snippet

Sponsor: Augusta University | Conditions: Schizophrenia | Phase 3 | Status: TERMINATED